156 related articles for article (PubMed ID: 11488674)
21. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
[TBL] [Abstract][Full Text] [Related]
22. Comparison of severity scoring of atopic dermatitis values and serum levels of eosinophil cationic protein and mast cell tryptase for routine evaluation of atopic dermatitis.
Amon U; Memmel U; Stoll R; Amon S
Acta Derm Venereol; 2000; 80(4):284-6. PubMed ID: 11028863
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of eosinophil cationic protein, eosinophil-derived neurotoxin and myeloperoxidase in infections with filariae and schistosomes.
Tischendorf FW; Brattig NW; Büttner DW; Pieper A; Lintzel M
Acta Trop; 1996 Dec; 62(3):171-82. PubMed ID: 9025985
[TBL] [Abstract][Full Text] [Related]
24. Indirect assessment of eosinophiluria in urinary schistosomiasis using eosinophil cationic protein (ECP) and eosinophil protein X (EPX).
Reimert CM; Ouma JH; Mwanje MT; Magak P; Poulsen LK; Vennervald BJ; Christensen NO; Kharazmi A; Bendtzen K
Acta Trop; 1993 Jun; 54(1):1-12. PubMed ID: 8103623
[TBL] [Abstract][Full Text] [Related]
25. Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis.
Winther L; Moseholm L; Reimert CM; Stahl Skov P; Kaergaard Poulsen L
Allergy; 1999 May; 54(5):436-45. PubMed ID: 10380774
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of eosinophil cationic protein and eosinophil protein x in pollen atopic patients with stable asthma and its relation with bronchial hyperresponsiveness.
Chivato T; Martínez D; Blasco R; Melgarejo M; Gómez de Terreros FJ; Laguna R
Allergol Immunopathol (Madr); 1996; 24(6):243-7. PubMed ID: 9010559
[TBL] [Abstract][Full Text] [Related]
27. [Peripheral eosinophil counts relates the improvement of the skin lesions of atopic dermatitis patients more sensitive than serum eosinophil cationic protein levels].
Nishimoto M; Numahara T; Nakashima K; Yoshida T
Arerugi; 1998 Jun; 47(6):591-6. PubMed ID: 9721450
[TBL] [Abstract][Full Text] [Related]
28. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein.
Taniuchi S; Chihara J; Kojima T; Yamamoto A; Sasai M; Kobayashi Y
J Dermatol Sci; 2001 May; 26(1):79-82. PubMed ID: 11323224
[TBL] [Abstract][Full Text] [Related]
29. Eosinophil-derived proteins in nasal lavage fluid of neonates of allergic parents and the development of respiratory symptoms during the first 6 months of life. Collaborative SPACE team. Study on the Prevention of Allergy in Children in Europe.
Frischer T; Halmerbauer G; Gartner C; Rath R; Tauber E; Schierl M; Koller DY; Urbanek R; Förster J; Kühr J
Allergy; 2000 Aug; 55(8):773-7. PubMed ID: 10955705
[TBL] [Abstract][Full Text] [Related]
30. Urinary eosinophilic protein X, atopy, and symptoms suggestive of allergic disease at 3 years of age.
Gore C; Peterson CG; Kissen P; Simpson BM; Lowe LA; Woodcock A; Custovic A;
J Allergy Clin Immunol; 2003 Oct; 112(4):702-8. PubMed ID: 14564347
[TBL] [Abstract][Full Text] [Related]
31. Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma.
Severien C; Artlich A; Jonas S; Becher G
Eur Respir J; 2000 Oct; 16(4):588-92. PubMed ID: 11106196
[TBL] [Abstract][Full Text] [Related]
32. Measurement of eosinophil cationic protein (ECP) and eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Time and temperature dependent spontaneous release in vitro demands standardized sample processing.
Reimert CM; Poulsen LK; Bindslev-Jensen C; Kharazmi A; Bendtzen K
J Immunol Methods; 1993 Dec; 166(2):183-90. PubMed ID: 8288872
[TBL] [Abstract][Full Text] [Related]
33. Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein.
Tsuda S; Kato K; Miyasato M; Sasai Y
J Dermatol; 1992 Apr; 19(4):208-13. PubMed ID: 1607481
[TBL] [Abstract][Full Text] [Related]
34. Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index.
Pucci N; Novembre E; Cammarata MG; Bernardini R; Monaco MG; Calogero C; Vierucci A
Allergy; 2005 Jan; 60(1):113-6. PubMed ID: 15575941
[TBL] [Abstract][Full Text] [Related]
35. High levels of urinary eosinophil protein X in young asthmatic children predict persistent atopic asthma.
Øymar K
Pediatr Allergy Immunol; 2001 Dec; 12(6):312-7. PubMed ID: 11846868
[TBL] [Abstract][Full Text] [Related]
36. Individual time-courses of ECP and EPX during allergen provocation tests in asthmatic children.
Kleinau I; Niggemann B; Wahn U
Pediatr Allergy Immunol; 1995 May; 6(2):109-18. PubMed ID: 7581720
[TBL] [Abstract][Full Text] [Related]
37. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
[TBL] [Abstract][Full Text] [Related]
38. Twenty-four-hour time course of eosinophil granule proteins ECP and EPX during bronchial allergen challenges in serum of asthmatic children.
Niggemann B; Kleinau I; Schmitt M; Wahn U
Allergy; 1994 Feb; 49(2):74-80. PubMed ID: 8172362
[TBL] [Abstract][Full Text] [Related]
39. Urinary eosinophil protein X in children with asthma: influence of atopy and airway infections.
Oymar K; Bjerknes R
Pediatr Allergy Immunol; 2001 Feb; 12(1):34-41. PubMed ID: 11251863
[TBL] [Abstract][Full Text] [Related]
40. [A fundamental study on clinical significance of measuring eosinophil protein X in spot urine in asthmatics].
Oosaki R; Mizushima Y; Kawasaki A; Fujishita T; Kawagishi Y; Mita H; Akiyama K; Kobayashi M
Arerugi; 1998 Dec; 47(12):1273-9. PubMed ID: 10028722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
